BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9587562)

  • 1. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type B lactic acidosis in an AIDS patient treated with zidovudine.
    Aggarwal A; al-Talib K; Alabrash M
    Md Med J; 1996 Nov; 45(11):929-31. PubMed ID: 8942169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.
    Chariot P; Drogou I; de Lacroix-Szmania I; Eliezer-Vanerot MC; Chazaud B; Lombès A; Schaeffer A; Zafrani ES
    J Hepatol; 1999 Jan; 30(1):156-60. PubMed ID: 9927163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rare etiology of hepatic steatosis associated with lactic acidosis: the toxicity of antiviral nucleoside analogues].
    Bienvenu L; Burel F; Hofman V; Itchaï C; Amaro J; Hofman P
    Ann Pathol; 2001 Apr; 21(2):160-3. PubMed ID: 11373588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.
    Posteraro AF; Mauriello M; Winter SM
    Conn Med; 2001 Jul; 65(7):387-90. PubMed ID: 11508132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
    Fielder J; Rambiki K
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.
    Miller RF; Shahmonesh M; Hanna MG; Unwin RJ; Schapira AH; Weller IV
    Antivir Ther; 2003 Jun; 8(3):253-7. PubMed ID: 12924544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?
    Le Bras P; D'Oiron R; Quertainmont Y; Halfon P; Caquet R
    AIDS; 1994 May; 8(5):716-7. PubMed ID: 8060560
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal lactic acidosis during antiretroviral therapy.
    Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
    Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
    Dieterich DT
    AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.
    Brinkman K
    Clin Infect Dis; 2000 Jul; 31(1):167-9. PubMed ID: 10913416
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitochondrial dysfunction in HIV infection: an overview of pathogenesis.
    Rustin P
    J HIV Ther; 2001 Mar; 6(1):4-12. PubMed ID: 11501198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.